Trio Pharmaceuticals, Aji Bio-Pharma to co-develop antibody drug conjugates

Trio Pharmaceuticals and Ajinomoto Bio-Pharma Services (Aji Bio-Pharma) have entered into a development collaboration agreement to assess AJICAP, a site-specific conjugation technology offered by the ... Read More